Astric cancer) to trastuzumab [23,24]. A significant reduction of primary tumor growth
Astric cancer) to trastuzumab . A significant reduction of primary tumor growth and of metastatic MedChemExpress 58-49-1 spread has previously been reported in an orthotopic model of HER2-positive esophageal adenocarcinoma…